Trial intelligence / Profile preview

Bolus eptifibatide versus bolus plus infusion in acute ST elevation myocardial infarction

IRCT20110512006463N3Phase 3Completed

Sponsor
Alborz University of Medical Sciences
Start
Apr 2018
Modality
Peptides
Countries
1
01

Overview

Phase 3 trial of eptifibatide in myocardial infarction (MI) (2 arms), sponsored by Alborz University of Medical Sciences. Started Apr 2018; status: completed.

02

Drugs

eptifibatide
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on IRCT20110512006463N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20110512006463N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call